Tameside and Glossop Integrated Care NHS Foundation Trust is an integrated foundation Trust that operates from Tameside General Hospital situated in Ashton-under-Lyne.

During the past decade, Tameside General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tameside General Hospital" #1 sponsor was "Institute of Cancer Research, United Kingdom" with 3 trials, followed by "Tameside General Hospital" with 3 trials sponsored, "Abbott Diabetes Care" with 2 trials sponsored, "Queen Mary University of London" with 2 trials sponsored and "Tameside Hospital NHS Foundation Trust" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tameside General Hospital" #1 collaborator was "Cancer Research UK" with 1 trials as a collaborator, "Imarc Research, Inc." with 1 trials as a collaborator, "LifeCell" with 1 trials as a collaborator, "Manchester Metropolitan University" with 1 trials as a collaborator and "The Christie NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Tameside General Hospital" are "Breast Cancer" (4 trials), "Diabetes Mellitus" (2 trials), "Prostate Cancer" (2 trials), "Bladder Cancer" (1 trials) and "Bone Diseases, Metabolic" (1 trials). Many other conditions were trialed in "Tameside General Hospital" in a lesser frequency.

Most popular intervention types in "Tameside General Hospital" are "Drug" (6 trials), "Device" (4 trials), "Other" (3 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "questionnaire administration" (2 trials), "ADC blood glucose meter" (1 trials), "ADC blood glucose meter with insulin calculator active" (1 trials) and "Anastrozole" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tameside General Hospital" are 12 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Tameside General Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Tameside General Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tameside General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".